Jamp Lenalidomide 10 mg – DIN 02506157
Jamp Lenalidomide is Lenalidomide 10 mg (capsule), sold in Canada. It is used for multiple myeloma and mantle-cell lymphoma. It is supplied by Jamp Pharma Corporation. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Lenalidomide 10 mg
- Brand
- Jamp Lenalidomide
- Strength
- 10 mg
- Used for
- Multiple myeloma and mantle-cell lymphoma
- Form
- Capsule
- Manufacturer
- Jamp Pharma Corporation
- Drug class
- Thalidomide analog
- Sold in
- Canada
- DIN
- 02506157
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Lenalidomide used for?
Lenalidomide is used for multiple myeloma and mantle-cell lymphoma.
- Medicine type
- Thalidomide analog
Official uses from the US prescribing label
Multiple Myeloma
Lenalidomide capsules in combination with dexamethasone is indicated for the treatment of adult patients with multiple myeloma (MM).
Lenalidomide capsules are indicated as maintenance therapy in adult patients with MM following autologous hematopoietic stem cell transplantation (auto-HSCT).
Myelodysplastic Syndromes
Lenalidomide capsules are indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
Mantle Cell Lymphoma
Lenalidomide capsules are indicated for the treatment of adult patients with mantle cell lymphoma (MCL) whose disease has relapsed or progressed after two prior therapies, one of which included bortezomib.
Follicular Lymphoma
Lenalidomide capsules in combination with a rituximab product, is indicated for the treatment of adult patients with previously treated follicular lymphoma (FL).
Marginal Zone Lymphoma
Lenalidomide capsules in combination with a rituximab product, is indicated for the treatment of adult patients with previously treated marginal zone lymphoma (MZL).
Limitations of Use
Lenalidomide capsules are not indicated and are not recommended for the treatment of patients with CLL outside of controlled clinical trials.
From the FDA-approved label on DailyMed (published Sep 15, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02506157.
- It names Jamp Lenalidomide, Lenalidomide 10 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Jamp Lenalidomide by Jamp Pharma Corporation.
In Canada: prescription only.
Ingredients
Active: Lenalidomide
Other Lenalidomide pills
-
AA19A
Lenalidomide 10 mg
Blue & yellow, capsule, 22 mm
Used for multiple myeloma and mantle-cell lymphoma
-
AA20A
Lenalidomide 15 mg
Blue & white, capsule, 22 mm
Used for multiple myeloma and mantle-cell lymphoma
-
AA17A
Lenalidomide 2.5 mg
Blue & white, capsule, 15 mm
Used for multiple myeloma and mantle-cell lymphoma
-
AA21A
Lenalidomide 20 mg
Blue, capsule, 22 mm
Used for multiple myeloma and mantle-cell lymphoma
-
AA22A
Lenalidomide 25 mg
White, capsule, 22 mm
Used for multiple myeloma and mantle-cell lymphoma
-
AA18A
Lenalidomide 5 mg
White, capsule, 18 mm
Used for multiple myeloma and mantle-cell lymphoma
- L 10 Lenalidomide 10 mg Green & orange, capsule, 21 mm Used for multiple myeloma and mantle-cell lymphoma
- RDY 10 mg Lenalidomide 10 mg Yellow, capsule, 18 mm Used for multiple myeloma and mantle-cell lymphoma